
inSoma Bio
inSoma Bio is a YC Summer 2020 (S20) company. Based in Durham, NC, USA. Team of 4.
About inSoma Bio
Summary
inSoma Bio develops injectable biomaterials for reconstructive plastic surgery, targeting procedures such as breast and facial reconstruction. Its core product, the Fractomer Biomatrix, is a recombinant protein-based material that supports a patient's own transplanted cells or tissue, replacing synthetic implants and fillers. Surgeons gain a bio-integrated scaffold produced at the genetic level, activated only at body temperature, without harvesting donor tissue.
Go-to-market
Plastic surgeons are the direct customer, reached through clinical and academic medical channels, with Duke University and advisory relationships at major surgical departments anchoring early adoption.
From the Y Combinator listing
Helping Plastic Surgeons Rebuild Fat
Facts
- Healthcare / Healthcare -> Medical Devices
- Durham, NC, USA
- 4
- Active
- Early
Founders (2)
- Ashutosh Chilkoti
- Stefan Roberts
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works